News Industry News Angionetics' Generx® [Ad5FGF-4] Gene Therapy Biologic Receives FDA Clearance For U.S. Phase 3 Clinical Study As A New, Single Dose, Treatment For Coronary Artery Disease September 12, 2016
News Industry News Micell Technologies Announces First Patient Enrolled in Registration Trial of MiStent SES in China July 22, 2015
News Industry News OrbusNeich Announces Enrollment of First Patient in China Recovery Study July 20, 2015